Guidance on home blood pressure monitoring: A statement of the HOPE Asia Network
- Title
- Guidance on home blood pressure monitoring: A statement of the HOPE Asia Network
- Author
- 신진호
- Keywords
- blood pressure control; clinical practice; guidelines; home blood pressure monitoring; hypertension; Pfizer
- Issue Date
- 2018-02
- Publisher
- WILEY
- Citation
- JOURNAL OF CLINICAL HYPERTENSION, v. 20, no. 3, page. 456-461
- Abstract
- Hypertension is an important modifiable cardiovascular risk factor and a leading cause of death throughout Asia. Effective prevention and control of hypertension in the region remain a significant challenge despite the availability of several regional and international guidelines. Out-of-office measurement of blood pressure (BP), including home BP monitoring (HBPM), is an important hypertension management tool. Home BP is better than office BP for predicting cardiovascular risk and HBPM should be considered for all patients with office BP130/85mmHg. It is important that HBPM is undertaken using a validated device and patients are educated about how to perform HBPM correctly. During antihypertensive therapy, monitoring of home BP control and variability is essential, especially in the morning. This is because HBPM can facilitate the choice of individualized optimal therapy. The evidence and practice points in this document are based on the Hypertension Cardiovascular Outcome Prevention and Evidence (HOPE) Asia Network expert panel consensus recommendations for HBPM in Asia.
- URI
- https://onlinelibrary.wiley.com/doi/full/10.1111/jch.13216https://repository.hanyang.ac.kr/handle/20.500.11754/117460
- ISSN
- 1524-6175; 1751-7176
- DOI
- 10.1111/jch.13216
- Appears in Collections:
- COLLEGE OF MEDICINE[S](의과대학) > MEDICINE(의학과) > Articles
- Files in This Item:
There are no files associated with this item.
- Export
- RIS (EndNote)
- XLS (Excel)
- XML